Organization
Active Biotech Research AB
2 abstracts
Abstract
A PHASE I, DOSE ESCALATION STUDY TO EVALUATE THE TOLERABILITY OF ABR-215757 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Org: Active Biotech Research AB,
Abstract
ABR-224050 A NOVEL DIHYDROOROTATE DEHYDROGENASE INHIBITOR SUPPRESSING DISEASE DEVELOPMENT IN COLLAGEN INDUCED ARTHRITIS IN DBA/1 MICEOrg: Research and Development Laboratories, Active Biotech Research AB, Lund, Sweden, Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Chelsea Therapeutics,